HELP committee confirms the markup is next Wednesday (Nov. 18)
Senate Committee To Vote On US FDA Commissioner Nominee Before Dem Takeover insights.citeline.com/pink-sheet/age…View quoted post on X
Maaisha Osman
@MaaishaO
health policy reporter @PharmaPinkSheet • cinephile
signal: maaisha.07
Send tips to maaisha.osman@citeline.com
signal: maaisha.07
Send tips to maaisha.osman@citeline.com
424 Following 325 Followers 813 Posts
Latest posts 5
Senate Committee To Vote On US FDA Commissioner Nominee Before Dem Takeover insights.citeline.com/pink-sheet/age…
insights.citeline.com Senate Committee To Vote On US FDA Commissioner Nominee Before Dem Takeover Outgoing Senate Health, Education, Labor and Pensions Committee Chair Bill Cassidy is planning a vote on Heidi Overton's nomination for FDA commissioner, while Acting Commissioner Kyle Diamantas'... HHS Peptide Policy Brushes Off US FDA Safety Concerns As Hypothetical
insights.citeline.com/pink-sheet/com…
insights.citeline.com/pink-sheet/com…
insights.citeline.com HHS Peptide Policy Brushes Off US FDA Safety Concerns As Hypothetical HHS, not the FDA, issued the enforcement discretion policy, and suggested FDA concerns about the safety of the unapproved peptides were not observed. Noting that the peptide FR notice is from HHS. Our story from earlier on how FDA staff pushed back on this: insights.citeline.com/pink-sheet/pro…
w/ @PinkSheetSutter
w/ @PinkSheetSutter
insights.citeline.com US FDA Staff Push Back Against Trump Administration Interim Peptide Dispensing Order FDA staff said the move to allow compounding of some unapproved peptide products raises patient safety concerns and weakens the drug approval process. Compounding policy is out: public-inspection.federalregister.gov/2026-22192.pdf…